MDMA is one step closer to becoming the first FDA-approved psychedelic drug. In October 2023, the Multidisciplinary Association for Psychedelic Studies (MAPS) announced it completed its phase three clinical trial...
More results...
MDMA is one step closer to becoming the first FDA-approved psychedelic drug. In October 2023, the Multidisciplinary Association for Psychedelic Studies (MAPS) announced it completed its phase three clinical trial...
Due to severe weather this past week, Boulder Weekly is currently experiencing phone outages. We have contacted our phone providers and repair technicians and hope to have this resolved soon. In the meantime, you can contact us via email at [email protected].